Signaling Pathways - c-MET - HDM2 ubiquitin ligase
清除全部
-
B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR抑制剂 -
A8448 INCB28060中文名: 苯扎米特Target: c-METSummary: C-Met抑制剂 -
A5057 MGCD-265Target: VEGFR|c-METSummary: Met/Flt/Flk/Ron/Tie-2抑制剂 -
A2412 CP-724714Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1RSummary: 有效的HER2选择性抑制剂 -
A5096 PF-04217903Target: c-METSummary: C-Met的选择性和ATP竞争性抑制剂 -
A2307 PHA-6657521 CitationTarget: c-METSummary: c-Met的ATP竞争性、有效的、选择性抑制剂 -
A3712 PF-04217903 methanesulfonateTarget: c-METSummary: c-Met抑制剂 -
A4204 JNJ-26854165 (Serdemetan)1 CitationTarget: p53|HDM2 ubiquitin ligaseSummary: P53激活剂，阻断Mdm2-p53相互作用。 -
A3020 (R)-Crizotinib2 Citation中文名: 克唑替尼Target: c-METSummary: ATP竞争性的C-MET/ALK抑制剂。